Skip to main content
Log in

Silymarin Attenuates Airway Inflammation Induced by Cigarette Smoke in Mice

  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

Cigarette smoke (CS), which increases inflammation and oxidative stress, is a major risk factor for the development of COPD. In this study, we investigated the effects of silymarin, a polyphenolic flavonoid isolated from the seeds and fruits of milk thistle, on CS-induced airway inflammation and oxidative stress in mice and the possible mechanisms. BALB/c mice were exposed to CS for 2 h twice daily, 6 days per week for 4 weeks. Silymarin (25, 50 mg/kg · day) was administered intraperitoneally 1 h before CS exposure. Bronchoalveolar lavage fluid (BALF) was acquired for cell counting and the detection of pro-inflammatory cytokine levels. Lung tissue was collected for histological examination, myeloperoxidase (MPO) activity assay, superoxide dismutase (SOD) activities, and malondialdehyde (MDA) levels. The phosphorylation of ERK and p38 was evaluated by Western blotting. Pretreatment with silymarin significantly attenuated CS-induced thickening of the airway epithelium, peribronchial inflammatory cell infiltration, and lumen obstruction. The numbers of total cells, macrophages, and neutrophils, along with the MPO activity (a marker of neutrophil accumulation) in BALF, were remarkably decreased by silymarin in CS-exposed mice (all p < 0.05). In addition, silymarin pretreatment dampened the secretion of TNF-α, IL-1β, and IL-8 in BALF. High-dose silymarin (50 mg/kg · day) administration also prevented CS-induced elevation in MDA levels and decrease in SOD activities (p < 0.05). Furthermore, the CS-induced phosphorylation of ERK and p38 was also attenuated by silymarin (p < 0.05). These results suggest that silymarin attenuated inflammation and oxidative stress induced by cigarette smoke. The anti-inflammatory effect might partly act through the mitogen-activated protein kinases (MAPK) pathway.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Cosio, M.G., M. Saetta, and A. Agusti. 2009. Immunologic aspects of chronic obstructive pulmonary disease. New England Journal of Medicine 360(23): 2445–2454.

    Article  CAS  PubMed  Google Scholar 

  2. Taylor, J.D. 2010. COPD and the response of the lung to tobacco smoke exposure. Pulmonary Pharmacology & Therapeutics 23(5): 376–383.

    Article  CAS  Google Scholar 

  3. Tetley, T.D. 2005. Inflammatory cells and chronic obstructive pulmonary disease. Current Drug Targets. Inflammation and Allergy 4(6): 607–618.

    Article  CAS  PubMed  Google Scholar 

  4. Milk Thistle (Silybum marianum) in PDR for herbal medicines. Montvale, NJ, Medical Economics Company, 2000: 516–520.

  5. Yang T, Luo F, Shen YC, An J, Li XO, Liu XY, Ying BW, Liao ZL, Dong JJ, Guo LL, Wang T, Xu D, Chen L, Wen FQ. 2012. Quercetin attenuates airway inflammation and mucus production induced by cigarette smoke in rats. International Immunopharmacology

  6. Song, Z., I. Deaciuc, M. Song, D.Y. Lee, Y. Liu, X. Ji, and C. McClain. 2006. Silymarin protects against acute ethanol-induced hepatotoxicity in mice. Alcoholism, Clinical and Experimental Research 30(3): 407–413.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  7. Zi, X., D.K. Feyes, and R. Agarwal. 1998. Anticarcinogenic effect of a flavonoid antioxidant, silymarin, in human breast cancer cells MDA-MB 468: induction of G1 arrest through an increase in Cip1/p21 concomitant with a decrease in kinase activity of cyclin-dependent kinases and associated cyclins. Clinical Cancer Research 4(4): 1055–1064.

    CAS  PubMed  Google Scholar 

  8. Féher, J., and G. Lengyel. 2012. Silymarin in the prevention and treatment of liver diseases and primary liver cancer. Current Pharmaceutical Biotechnology 13(1): 210–217.

    Article  PubMed  Google Scholar 

  9. Gazák, R., D. Walterová, and V. Kren. 2007. Silybin and silymarin-new and emerging applications in medicine. Current Medicinal Chemistry 14(3): 315–338.

    Article  PubMed  Google Scholar 

  10. Naveen, K.S., S. Garima, K.P. Devendra, K.J. Swatantra, and P.S. Mahendra. 2011. Melatonin or silymarin reduces maneb- and paraquat-induced Parkinson’s disease phenotype in the mouse. Journal of Pineal Research 50: 97–109.

    Google Scholar 

  11. Chen, L., B.B. Sun, T. Wang, X. Wang, J.Q. Li, H.X. Wang, S.F. Zhang, D.S. Liu, L. Liu, D. Xu, X.M. Ou, Y.J. Chen, T. Yang, H. Zhou, and F.Q. Wen. 2010. Cigarette smoke enhances β-defensin 2 expression in rat airways via nuclear factor-κB activation. European Respiratory Journal 36(3): 638–645.

    Article  CAS  PubMed  Google Scholar 

  12. Toklu, H.Z., T. Tunali Akbay, A. Velioglu-Ogunc, F. Ercan, N. Gedik, M. Keyer-Uysal, and G. Sener. 2008. Silymarin, the antioxidant component of Silybum marianum, prevents sepsis-induced acute lung and brain injury. Journal of Surgical Research 145(2): 214–222.

    Article  CAS  PubMed  Google Scholar 

  13. Choi, Y.H., G.Y. Jin, H.S. Guo, H.M. Piao, Li. Lc, G.Z. Li, Z.H. Lin, and G.H. Yan. 2012. Silibinin attenuates allergic airway inflammation in mice. Biochemical and Biophysical Research Communications 427(3): 450–455.

    Article  CAS  PubMed  Google Scholar 

  14. Boeckenholt, C., F. Begrow, and E.J. Verspohl. 2012. Effect of silymarin and harpagoside on inflammation reaction of BEAS-2B cells, on ciliary beat frequency (CBF) of trachea explants and on mucociliary clearance (MCC). Planta Medica 78(8): 761–766.

    Article  CAS  PubMed  Google Scholar 

  15. Hwang, J.W., S. Rajendrasozhan, H. Yao, S. Chung, I.K. Sundar, H.L. Huyck, G.S. Pryhuber, V.L. Kinnula, and I. Rahman. 2011. FOXO3 deficiency leads to increased susceptibility to cigarette smoke-induced inflammation, airspace enlargement, and chronic obstructive pulmonary disease. Journal of Immunology 187: 987–998.

    Article  CAS  Google Scholar 

  16. Arnson, Y., Y. Shoenfeld, and H. Amital. 2010. Effects of tobacco smoke on immunity, inflammation and autoimmunity. Journal of Autoimmunity 34(3): J258–265.

    Article  CAS  PubMed  Google Scholar 

  17. Kirkham, P., and I. Rahman. 2006. Oxidative stress in asthma and COPD: antioxidants as a therapeutic strategy. Pharmacology and Therapeutics 111(2): 476–494.

    Article  CAS  PubMed  Google Scholar 

  18. Altaei, T. 2012. Protective effect of silymarin during coronary artery bypass grafting surgery. Experimental and Clinical Cardiology 17(1): 34–38.

    PubMed Central  PubMed  Google Scholar 

  19. Hou, Y.C., K.T. Liou, C.M. Chern, Y.H. Wang, J.F. Liao, S. Chang, Y.H. Chou, and Y.C. Shen. 2010. Preventive effect of silymarin in cerebral ischemia-reperfusion-induced brain injury in rats possibly through impairing NF-κB and STAT-1 activation. Phytomedicine 17(12): 963–973.

    Article  CAS  PubMed  Google Scholar 

  20. Zhao, J., M. Lahiri-Chatterjee, Y. Sharma, and R. Agarwal. 2000. Inhibitory effect of a flavonoid antioxidant silymarin on benzoyl peroxide-induced tumor promotion, oxidative stress and inflammatory responses in SENCAR mouse skin. Carcinogenesis 21: 811.

    Article  CAS  PubMed  Google Scholar 

  21. Bosisio, E., C. Benelli, and O. Pirola. 1992. Effect of the flavanolignans of Silybum marianum L. on lipid peroxidation in rat liver microsomes and freshly isolated hepatocytes. Pharmacological Research 25: 147.

    Article  CAS  PubMed  Google Scholar 

  22. Soto, C., R. Recoba, H. Barrón, C. Alvarez, and L. Favari. 2003. Silymarin increases antioxidant enzymes in alloxan-induced diabetes in rat pancreas. Comparative Biochemistry and Physiology C-Toxicology & Pharmacology 136: 205.

    Article  Google Scholar 

  23. Zhao, J., R. Harper, A. Barchowsky, and Y.P. Di. 2007. Identification of multiple MAPK-mediated transcription factors regulated by tobacco smoke in airway epithelial cells. American Journal of Physiology. Lung Cellular and Molecular Physiology 293: L480–490.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  24. Junttila, M.R., S.P. Li, and J. Westermarck. 2008. Phosphatase-mediated crosstalk between MAPK signaling pathways in the regulation of cell survival. FASEB Journal 22: 954–965.

    Article  CAS  PubMed  Google Scholar 

  25. Cossa, G., L. Gatti, G. Cassinelli, C. Lanzi, N. Zaffaroni, and P. Perego. 2013. Modulation of sensitivity to antitumor agents by targeting the MAPK survival pathway. Current Pharmaceutical Design 19(5): 883–894.

    Article  CAS  PubMed  Google Scholar 

  26. Renda, T., S. Baraldo, G. Pelaia, E. Bazzan, G. Turato, A. Papi, P. Maestrelli, R. Maselli, A. Vatrella, L.M. Fabbri, R. Zuin, S.A. Marsico, and M. Saetta. 2008. Increased activation of p38 MAPK in COPD. European Respiratory Journal 31: 62–69.

    Article  CAS  PubMed  Google Scholar 

  27. Rahman, I., and W. MacNee. 1998. Role of transcription factors in inflammatory lung diseases. Thorax 53: 601–612.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  28. Chung, K.F. 2011. p38 mitogen-activated protein kinase pathways in asthma and COPD. Chest 139: 1470–1479.

    Article  CAS  PubMed  Google Scholar 

  29. Gaffey, K., S. Reynolds, J. Plumb, M. Kaur, and D. Singh. 2013. Increased phosphorylated p38 mitogen-activated protein kinase in COPD lungs. European Respiratory Journal 42(1): 28–41.

    Article  CAS  PubMed  Google Scholar 

  30. Mehra, D., P.M. Geraghty, A.A. Hardigan, and R.A. Foronjy. 2012. Comparison of the inflammatory and proteolytic effects of dung biomass and cigarette smoke exposure in the lung. PloS One 7(12): e52889.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by grants 31171103 and 81230001 from the National Natural Science Foundation of China and 06–834 from the China Medical Board of New York to Dr Fu-Qiang Wen.

Conflicts of Interest

We declare that we have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Fuqiang Wen.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, D., Xu, D., Wang, T. et al. Silymarin Attenuates Airway Inflammation Induced by Cigarette Smoke in Mice. Inflammation 38, 871–878 (2015). https://doi.org/10.1007/s10753-014-9996-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10753-014-9996-9

KEY WORDS

Navigation